Eli Lilly (LLY) Canada Inc. said it is disappointed and strongly disagrees with Canada’s Drug Agency’s Final Recommendation for Ebglyss, published on Friday, November 15, 2024. The CDA-AMC recommended ...
Eli Lilly posted third-quarter earnings of $1.94 a share, 2 cents below analysts’ estimates, but the stock was rising after the drug giant boosted its full-year guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results